mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
4e-12 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-10 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-10 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-09 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.23 |
5e-09 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-08 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
2e-08 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
3e-08 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
1e-07 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |